Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong · Delayed Price · Currency is HKD 16.76
-0.29 (-1.70%)
Nov 11, 2026, 4:08 PM HKT
Sinopharm Group Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Sinopharm Group stock has a consensus rating of "Buy" and an average price target of $20.12. The average 1-year stock price forecast is 20.05% higher than the current stock price, while the lowest is $17.19 (+2.57%) and the highest is $24.29 (+44.93%).
Price Target: $20.12 (+20.05%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Sinopharm Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 7 | 7 | 5 |
| Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Hold | 4 | 3 | 4 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 13 | 14 | 15 | 15 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $24.70 → $21.25 | Buy | Maintains | $24.70 → $21.25 | +26.79% | Oct 28, 2026 |
Unknown Analyst Citi No rating | Citi | Buy Maintains $20.40 → $20.50 | Buy | Maintains | $20.40 → $20.50 | +22.32% | Oct 28, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $21.10 | Buy | Maintains | $21.10 | +25.89% | Aug 25, 2026 |
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $21.00 | Buy | Maintains | $21.00 | +25.30% | Jul 1, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains $23.00 | Buy | Maintains | $23.00 | +37.23% | May 14, 2026 |
Financial Forecast
Revenue This Year
580.26B
from 575.17B
Increased by 0.89%
Revenue Next Year
598.27B
from 580.26B
Increased by 3.10%
EPS This Year
2.35
from 2.29
Increased by 2.73%
EPS Next Year
2.49
from 2.35
Increased by 5.68%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.